❓Are genetic testing startups a goldmine or gamble?
The genetic testing industry has seen both triumphs and setbacks. 23andMe, once a high-flyer, faces layoffs and declining market value. Yet others, like prenatal-focused Natera, thrive with multibillion-dollar valuations. Startups like BillionToOne and Genome Medical are raising hefty funds, while niches like pet DNA testing lose steam.
Despite past bubbles, the $10B genetic testing market is predicted to double by 2033, hinting at massive growth opportunities, but not without risks.
❓Are genetic testing startups a goldmine or gamble?
The genetic testing industry has seen both triumphs and setbacks. 23andMe, once a high-flyer, faces layoffs and declining market value. Yet others, like prenatal-focused Natera, thrive with multibillion-dollar valuations. Startups like BillionToOne and Genome Medical are raising hefty funds, while niches like pet DNA testing lose steam.
Despite past bubbles, the $10B genetic testing market is predicted to double by 2033, hinting at massive growth opportunities, but not without risks.
Now safely in France with his spouse and three of his children, Kliuchnikov scrolls through Telegram to learn about the devastation happening in his home country. Stocks closed in the red Friday as investors weighed upbeat remarks from Russian President Vladimir Putin about diplomatic discussions with Ukraine against a weaker-than-expected print on U.S. consumer sentiment. "Like the bombing of the maternity ward in Mariupol," he said, "Even before it hits the news, you see the videos on the Telegram channels." Telegram was founded in 2013 by two Russian brothers, Nikolai and Pavel Durov. Russian President Vladimir Putin launched Russia's invasion of Ukraine in the early-morning hours of February 24, targeting several key cities with military strikes.
from us
